• Lysergic Acid Diethylamide, Urine
  • Fine Needle Aspiration Biopsy and Fine Needle Core Biopsy
  • Group A Streptococcus (Streptococcus pyogenes), Culture
  • Propoxyphene, Serum
  • Clozapine, Serum
  • Creatinine, 24 Hour, Urine
  • Pheochromocytoma
  • Rhesus D (Rh D), Typing
  • Immunoglobulin Gene Rearrangement (B-Cell Clonality), Blood
  • Tuberculosis Cell Mediated Immunity Antigen Response (QuantiFERON®-TB Gold ) Test
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Turnaround Time
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.